Timothy B. Lowinger
Overview
Timothy B. Lowinger received an average of $1M in total compensation, including $407K in salary, at Mersana Therapeutics from 2016 to 2023.
2023Mersana TherapeuticsSenior Vice President, Chief Science and Technology Officer
2022Mersana TherapeuticsChief Science and Technology Officer
2021Mersana TherapeuticsSenior Vice President, Chief Science and Technology Officer
2020Mersana TherapeuticsChief Science and Technology Officer
2019Mersana TherapeuticsChief Science and Technology Officer
2018Mersana TherapeuticsSenior Vice President and Chief Scientific Officer
2017Mersana TherapeuticsSenior Vice President and Chief Scientific Officer
2016Mersana TherapeuticsSenior Vice President and Chief Scientific Officer
Source: SEC filings on April 26, 2024, April 28, 2023, April 29, 2022, April 27, 2021, April 23, 2019, and April 30, 2018.
Related executives
We found 11 more executives who work or worked at Mersana Therapeutics.
Anna Protopapas
Mersana Therapeutics
Chief Executive Officer
Martin Huber
Mersana Therapeutics
Chief Executive Officer
Arvin Yang
Mersana Therapeutics
Chief Medical Officer
Brian DeSchuytner
Mersana Therapeutics
Chief Financial Officer
Alejandra Carvajal
Mersana Therapeutics
Chief Legal Officer
Mohan Bala
Mersana Therapeutics
Senior Vice President, Chief Development Officer
Michael Kaufman
Mersana Therapeutics
Former Chief Manufacturing Officer
Tushar Misra
Mersana Therapeutics
Senior Vice President, Chief Manufacturing Officer
News
Mersana Therapeutics CEO Anna Protopapas' 2023 pay jumps 56% to $4.5M
April 26, 2024
Mersana Therapeutics CEO Anna Protopapas' 2022 pay falls 66% to $2.8M
April 28, 2023
Mersana Therapeutics CEO Anna Protopapas' 2021 pay jumps 226% to $8.3M
April 29, 2022
Mersana Therapeutics Chief Medical Officer Arvin Yang receives $4.5M in 2020
April 27, 2021
Mersana Therapeutics CEO Anna Protopapas' 2019 pay falls 33% to $1.7M
April 20, 2020
Mersana Therapeutics CEO Anna Protopapas' 2018 pay jumps 184% to $2.6M
April 23, 2019